The European Pharmacovigilance & Clinical Trials 2016 offers a one of a kind discussion platform for pharmaceutical experts to debate and discuss the challenges they are facing in Pharmacovigilance and Clinical Trials.

Do not miss out on the chance to acquire first-hand knowledge and experiences from pharmaceutical giants such as AstraZeneca, Merck Sereno, Boehringer Ingelheim, Pfizer, Novo Nordisk, Johnson & Johnson, Novartis and many more on the latest technological advances in data capture and effective feasibility models. We will be addressing topics such as Major challenges faced by EU legislation and Emerging Economies and PV Harmonization, Adverse event reporting and PV & clinical trials, Clinical Trials Signal Detection and many others. Join us and be future ready!

 Take advantage to meet the leading experts within the field and discuss the latest challenges all your competitors are facing.

We are looking forward to welcoming you on board in 2016!

KEY HIGHLIGHTS:        

• Harmonization and Pharmacovigilance
• PV regulations and challenges
• The new EU legislation on clinical trials, its impact and future
• Risk management and minimization
• Adverse drug reactions reporting
• Signal detection and post authorization safety
• Business development and models in clinical trials
• Clinical data management
• Good Clinical Practices and Good Pharmacovigilance practices
• IT and new technologies for improvement of PV and clinical research
• Strategies to improve clinical trials and PV